Status:
COMPLETED
Reverse Total Shoulder Arthroplasty in Patients Who Exceeded Their Life-expectancy: a Retrospective Study
Lead Sponsor:
Bürgerspital Solothurn
Conditions:
Reverse Total Shoulder Arthroplasty
Eligibility:
All Genders
83+ years
Brief Summary
Reverse total shoulder arthroplasty (RTSA) has become an established treatment for cuff arthropathy, severe osteoarthritis and in certain fracture cases. Due to the increasingly aging population, pati...
Detailed Description
This is a retrospective single institution study. All patients older than 83 years who received a reverse shoulder arthroplasty from 2008 until 2019 are included. Elective cases are compared to fractu...
Eligibility Criteria
Inclusion
- Patients older than 83 years at time of surgery
- Patients who received a reverse total shoulder arthroplasty
Exclusion
- Patients younger than 83 years at time of surgery
Key Trial Info
Start Date :
March 24 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 21 2020
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04807322
Start Date
March 24 2019
End Date
December 21 2020
Last Update
March 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bürgerspital Solothurn
Solothurn, Switzerland, 4500